THE RESULTS OF THE EFFICACY AND SAFETY OF THE NEW RUSSIAN DRUG 6НР IN THE ANTIRETROVIRAL THERAPY REGIMENS OF HIV-INFECTED PATIENTS
The aim of the study was to assess the efficacy and safety of ART regimens that included different doses of the drug 6НР with the reception of QD, in comparison with the scheme of ART, containing, PhAZT, to select the daily dose 6НР in conducting phase III clinical trials.Patients and methods. 125 p...
Main Authors: | A. V. Kravchenko, N. V. Sizova, S. V. Minaeva, O. A. Kozyrev, F. I. Nagimova, O. S. Efremova, D. A. Gusev, E. V. Ovsyannikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Journal Infectology
2019-03-01
|
Series: | Журнал инфектологии |
Subjects: | |
Online Access: | https://journal.niidi.ru/jofin/article/view/848 |
Similar Items
-
Comparison of efficacy and safety of antiretroviral first-line therapy with phosphazideortdf
by: A. V. Kravchenko, et al.
Published: (2018-12-01) -
Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
by: A. V. Kravchenko, et al.
Published: (2018-07-01) -
A TYPICAL PATIENT WITH HIV TODAY: COMPREHENSIVE CHARACTERIZATION AND ANTIRETROVIRAL TREATMENT OPTIONS (BASED ON DATA OF THE ST. PETERSBURG AIDS CENTER)
by: D. A. Gusev, et al.
Published: (2018-04-01) -
EVALUATION OF THE EFFICACY AND SAFETY OF THE ART REGIMENS CONTAINING LOW DOSES PHOSPHAZID
by: N. V. Sizova, et al.
Published: (2017-10-01) -
CONCOMITANT DISEASES AND RISK FACTORS FOR THEIR DEVELOPMENT IN PATIENTS WITH HIV INFECTION OLDER THAN 40 YEARS
by: D. A. Gusev, et al.
Published: (2017-10-01)